Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 6
2011 2
2013 1
2014 3
2015 1
2017 1
2018 2
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Oseltamivir in pregnancy and birth outcomes.
Ehrenstein V, Kristensen NR, Monz BU, Clinch B, Kenwright A, Sørensen HT. Ehrenstein V, et al. BMC Infect Dis. 2018 Oct 16;18(1):519. doi: 10.1186/s12879-018-3423-z. BMC Infect Dis. 2018. PMID: 30326840 Free PMC article.
Oseltamivir is used to treat influenza and to provide post-exposure prophylaxis. We examined the association between oseltamivir use during pregnancy and birth outcomes. ...There was no evidence of an association between prenatal exposure to
Oseltamivir is used to treat influenza and to provide post-exposure prophylaxis. We examined the association between oseltamivir
Oseltamivir use in pregnancy: Risk of birth defects, preterm delivery, and small for gestational age infants.
Chambers CD, Johnson D, Xu R, Luo Y, Jones KL; OTIS Collaborative Research Group. Chambers CD, et al. Birth Defects Res. 2019 Nov 15;111(19):1487-1493. doi: 10.1002/bdr2.1566. Epub 2019 Aug 8. Birth Defects Res. 2019. PMID: 31397112
BACKGROUND: Influenza infection during pregnancy increases risks for adverse outcomes for both mother and fetus. For this reason, treatment for infection or postexposure prophylaxis with a neuraminidase inhibitor, such as oseltamivir, may be needed. ...RESULT …
BACKGROUND: Influenza infection during pregnancy increases risks for adverse outcomes for both mother and fetus. For this reas …
Influenza virus infection in pregnancy: a review.
Meijer WJ, van Noortwijk AG, Bruinse HW, Wensing AM. Meijer WJ, et al. Acta Obstet Gynecol Scand. 2015 Aug;94(8):797-819. doi: 10.1111/aogs.12680. Epub 2015 Jun 13. Acta Obstet Gynecol Scand. 2015. PMID: 26012384 Free article. Review.
OBJECTIVE: To provide information on the influence of influenza virus infection during pregnancy on maternal health and pregnancy outcome and on the effect of treatment and vaccination. ...For hospitalized patients, increased rates of preterm birth and …
OBJECTIVE: To provide information on the influence of influenza virus infection during pregnancy on maternal health and pregnancy
The safety of oseltamivir in pregnancy: an updated review of post-marketing data.
Wollenhaupt M, Chandrasekaran A, Tomianovic D. Wollenhaupt M, et al. Pharmacoepidemiol Drug Saf. 2014 Oct;23(10):1035-42. doi: 10.1002/pds.3673. Epub 2014 Jul 4. Pharmacoepidemiol Drug Saf. 2014. PMID: 24995623 Review.
RESULTS: Of the 2926 maternal exposures to oseltamivir retrieved from the Safety Database, pregnancy outcomes were known for 2128 women. ...A review of these and other case reports of birth defects did not suggest that they resulted from oseltamivir
RESULTS: Of the 2926 maternal exposures to oseltamivir retrieved from the Safety Database, pregnancy outcomes were know …
Safety of oseltamivir in pregnancy: a review of preclinical and clinical data.
Donner B, Niranjan V, Hoffmann G. Donner B, et al. Drug Saf. 2010 Aug 1;33(8):631-42. doi: 10.2165/11536370-000000000-00000. Drug Saf. 2010. PMID: 20635821 Review.
Of 232 maternal exposures to oseltamivir in the Roche database, pregnancy outcomes were known for 115 of these exposures. The incidence of adverse pregnancy outcomes was as follows: spontaneous abortions 6.1% (7/115), therapeutic abortions 11.3% …
Of 232 maternal exposures to oseltamivir in the Roche database, pregnancy outcomes were known for 115 of these exposure …
Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study.
Graner S, Svensson T, Beau AB, Damase-Michel C, Engeland A, Furu K, Hviid A, Håberg SE, Mølgaard-Nielsen D, Pasternak B, Kieler H. Graner S, et al. BMJ. 2017 Feb 28;356:j629. doi: 10.1136/bmj.j629. BMJ. 2017. PMID: 28246106 Free PMC article. Clinical Trial.
Infants were defined as exposed if the women filled a prescription during pregnancy for either of the two neuraminidase inhibitors oseltamivir or zanamivir.Main outcomes Low birth weight, low Apgar score, preterm birth, small for gestational age …
Infants were defined as exposed if the women filled a prescription during pregnancy for either of the two neuraminidase inhibitors …
Birth outcomes among women exposed to neuraminidase inhibitors during pregnancy.
Svensson T, Granath F, Stephansson O, Kieler H. Svensson T, et al. Pharmacoepidemiol Drug Saf. 2011 Oct;20(10):1030-4. doi: 10.1002/pds.2194. Epub 2011 Jul 19. Pharmacoepidemiol Drug Saf. 2011. PMID: 21774030
PURPOSE: To compare birth outcomes between women exposed and unexposed to the antiviral medications oseltamivir or zanamivir during pregnancy. ...None of the women exposed to oseltamivir or zanamivir had been admitted to hospital for influenza d …
PURPOSE: To compare birth outcomes between women exposed and unexposed to the antiviral medications oseltamivir or zana …
Safety of oseltamivir during pregnancy: a comparative study using the EFEMERIS database.
Beau AB, Hurault-Delarue C, Vial T, Montastruc JL, Damase-Michel C, Lacroix I. Beau AB, et al. BJOG. 2014 Jun;121(7):895-900. doi: 10.1111/1471-0528.12617. Epub 2014 Feb 11. BJOG. 2014. PMID: 24512604 Free article. Clinical Trial.
OBJECTIVE: To compare pregnancy outcome between women exposed and unexposed to oseltamivir during pregnancy. DESIGN: A comparative observational cohort study of women exposed to oseltamivir during pregnancy. ...CONCLUSIONS: There was no s …
OBJECTIVE: To compare pregnancy outcome between women exposed and unexposed to oseltamivir during pregnancy. DES …
Influenza A/H1N1v in pregnancy: an investigation of the characteristics and management of affected women and the relationship to pregnancy outcomes for mother and infant.
Yates L, Pierce M, Stephens S, Mill AC, Spark P, Kurinczuk JJ, Valappil M, Brocklehurst P, Thomas SH, Knight M. Yates L, et al. Health Technol Assess. 2010 Jul;14(34):109-82. doi: 10.3310/hta14340-02. Health Technol Assess. 2010. PMID: 20630123 Free article.
Outcomes examined in hospitalised women included maternal death, admission to an intensive care unit, perinatal mortality and preterm birth. ...Further research is needed on longer-term outcomes for infants exposed to AH1N1v influenza, antiviral drugs or vacc
Outcomes examined in hospitalised women included maternal death, admission to an intensive care unit, perinatal mortality and preterm
Safety of influenza immunizations and treatment during pregnancy: the Vaccines and Medications in Pregnancy Surveillance System.
Schatz M, Chambers CD, Jones KL, Louik C, Mitchell AA. Schatz M, et al. Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S64-8. doi: 10.1016/j.ajog.2011.01.047. Epub 2011 Feb 18. Am J Obstet Gynecol. 2011. PMID: 21333964
The Vaccines and Medications in Pregnancy Surveillance System (VAMPSS) has been designed to assess systematically the safety of vaccines and medications during pregnancy and is suited ideally to evaluate the gestational safety of seasonal and pandemic influenza vacc …
The Vaccines and Medications in Pregnancy Surveillance System (VAMPSS) has been designed to assess systematically the safety of vacci …
18 results
Jump to page
Feedback